Delivery Order SPE2DB22D2211-SPE2DB25FRSXT
- Not listed
- This federal contract award, with ID SPE2DB20D3111|SPE2DB25FA6PK, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,170.73 firm-fixed-price delivery order is for the supply of CALCIPOTRIENE 0.005% SOLUTION 60ML, a specialty pharmaceutical product. The contract has a performance period through February 3, 2025 and was awarded on January 31, 2025. The award is not designated as a set-aside...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,524.40, is for the delivery of Calcipotriene 0.005% Solution, a topical medication, with an ultimate completion date of April 2, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,406.73 firm fixed-price delivery order is for the supply of 60 gram tubes of Calcipotriene 0.005% cream. The contract has an ultimate completion date of January 6, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,111.00 firm fixed-price delivery order contract is for the supply of Calcipotriene 0.005% Cream, a dermatological medication, to support military healthcare programs. The contract is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at...
- This federal contract award is a Delivery Order (DO) valued at $1,621.71, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Calcipotriene 0.005% Solution, a dermatological medication, with a performance period ending on November 16, 2022. The contract is a Firm Fixed Price type and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,227.71 firm fixed-price delivery order is for the supply of 60g tubes of Calcipotriene 0.005% cream, a topical treatment. The contract has a period of performance through June 17, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,738.26, is for the supply of 60ml bottles of Calcipotriene 0.005% solution, a topical medication used in the treatment of psoriasis. The award does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,294.61 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Calcipotriene 0.005% solution (60ml). This order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded by DLA to Amerisourcebergen Drug Corp, which serves as the primary vehicle for the company to provide pharmaceutical products and medical...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, involves the delivery of Calcipotriene 0.005% Cream 60GM to the Defense Logistics Agency (DLA). The $1,078.78 Firm Fixed Price delivery order was issued under the company's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a wide range of pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,727.62 to AmerisourceBergen Drug Corp for the supply of Calcipotriene 0.005% Solution in 60ml quantities. The contract was competitively awarded on September 9, 2025, with an ultimate completion date of September 10, 2025, and utilizes firm fixed pricing. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this award. This delivery...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FRSXTDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,751.96 firm fixed-price delivery order is for the supply of CALCIPOTRIENE 0.005% SOLUTION 60ML, a pharmaceutical product. The contract has an ultimate completion date of March 11, 2025 and was awarded on March 10, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 3/10/25 |